Literature DB >> 19097193

Anatomy, physiology, and pathophysiology of the pedunculopontine nucleus.

Ned Jenkinson1, Dipanker Nandi, Kalai Muthusamy, Nicola J Ray, Ralph Gregory, John F Stein, Tipu Z Aziz.   

Abstract

The pedunculopontine nucleus is composed of cholinergic and non-cholinergic neurones and is located in the caudal pontomesencephalic tegmentum. Evidence suggests that the nucleus plays a role in the production and control of movement. The nucleus has dense interconnections with the basal ganglia, as well as with other areas of the brain associated with motor control. Electrical stimulation of the pedunculopontine nucleus in the decerebrate cat or rat produces organized locomotor movements. Physiological studies show that the pedunculopontine nucleus modulates its activity in response to locomotion, as well as voluntary arm and eye movements. Degeneration of the pedunculopontine nucleus is seen in post-mortem brains in humans with Parkinson's disease and Parkinsonian syndromes. In animal models of Parkinson's disease, metabolic changes are seen in the pedunculopontine nucleus, and chemical inhibition or mechanical disruption of the nucleus can produce an akinetic state in animals and man. In this paper we review the literature in support of the suggestion that some of the symptoms of Parkinson's disease are caused by dysfunction of the pedunculopontine nucleus. In accordance with this view, direct stimulation of the nucleus can ameliorate some symptoms of the disease, as demonstrated in both experimental animals and man. (c) 2008 Movement Disorder Society.

Entities:  

Mesh:

Year:  2009        PMID: 19097193     DOI: 10.1002/mds.22189

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  53 in total

1.  Cholinergic cells in the tegmentum send branching projections to the inferior colliculus and the medial geniculate body.

Authors:  S D Motts; B R Schofield
Journal:  Neuroscience       Date:  2011-01-26       Impact factor: 3.590

2.  Understanding the human pedunculopontine nucleus in Parkinson's disease.

Authors:  Anders Fytagoridis; Peter A Silburn; Terry J Coyne; Wesley Thevathasan
Journal:  J Neural Transm (Vienna)       Date:  2016-01-16       Impact factor: 3.575

Review 3.  Restoration of locomotive function in Parkinson's disease by spinal cord stimulation: mechanistic approach.

Authors:  Romulo Fuentes; Per Petersson; Miguel A L Nicolelis
Journal:  Eur J Neurosci       Date:  2010-10       Impact factor: 3.386

4.  Mental steps: Differential activation of internal pacemakers in motor imagery and in mental imitation of gait.

Authors:  Lucia Maria Sacheli; Laura Zapparoli; Carlo De Santis; Matteo Preti; Catia Pelosi; Nicola Ursino; Alberto Zerbi; Giuseppe Banfi; Eraldo Paulesu
Journal:  Hum Brain Mapp       Date:  2017-07-21       Impact factor: 5.038

Review 5.  An integrative role for the superior colliculus in selecting targets for movements.

Authors:  Andrew B Wolf; Mario J Lintz; Jamie D Costabile; John A Thompson; Elizabeth A Stubblefield; Gidon Felsen
Journal:  J Neurophysiol       Date:  2015-07-22       Impact factor: 2.714

6.  Cerebral cortical and subcortical cholinergic deficits in parkinsonian syndromes.

Authors:  S Gilman; R A Koeppe; B Nan; C-N Wang; X Wang; L Junck; R D Chervin; F Consens; A Bhaumik
Journal:  Neurology       Date:  2010-05-04       Impact factor: 9.910

Review 7.  The pathology roadmap in Parkinson disease.

Authors:  D James Surmeier; David Sulzer
Journal:  Prion       Date:  2013-01-01       Impact factor: 3.931

8.  Projections from auditory cortex to midbrain cholinergic neurons that project to the inferior colliculus.

Authors:  B R Schofield
Journal:  Neuroscience       Date:  2009-12-13       Impact factor: 3.590

Review 9.  Parkinson's disease.

Authors:  Timothy R Mhyre; James T Boyd; Robert W Hamill; Kathleen A Maguire-Zeiss
Journal:  Subcell Biochem       Date:  2012

10.  Postural motor learning in people with Parkinson's disease.

Authors:  Daniel S Peterson; Bauke W Dijkstra; Fay B Horak
Journal:  J Neurol       Date:  2016-05-18       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.